We then compared CTSD expression in AML patients and healthy donors using the Gene Expression Profiling Interactive Analysis (GEPIA) database (http://gepia.cancer-pku.cn) and found that CTSD levels were significantly elevated in AML patients (Fig. 1B). The gene discussed is CTSD; the disease is acute myeloid leukemia.